IRVINE, CA -- (MARKET WIRE) -- November 15, 2006 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that President and CEO Jeffrey W. Jones and CFO Richard L. Harrison are scheduled to make an investor presentation at the Lazard Capital Markets Third Annual Life Sciences Conference at 11:00 a.m. (Eastern) on Tuesday, November 28.
